M. Gattinara

1.3k total citations
49 papers, 818 citations indexed

About

M. Gattinara is a scholar working on Hematology, Rheumatology and Speech and Hearing. According to data from OpenAlex, M. Gattinara has authored 49 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 26 papers in Rheumatology and 11 papers in Speech and Hearing. Recurrent topics in M. Gattinara's work include Autoimmune and Inflammatory Disorders Research (32 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Adolescent and Pediatric Healthcare (11 papers). M. Gattinara is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (32 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Adolescent and Pediatric Healthcare (11 papers). M. Gattinara collaborates with scholars based in Italy, United States and Slovakia. M. Gattinara's co-authors include V. Gerloni, F Fantini, Irene Pontikaki, Rolando Cimaz, Micol Romano, Claudia Lomater, Pier Luigi Meroni, Elisabetta Miserocchi, Giulio Modorati and Dimitri Poddighe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Current Medicinal Chemistry.

In The Last Decade

M. Gattinara

44 papers receiving 795 citations

Peers

Countries citing papers authored by M. Gattinara

Since Specialization

Citations

This map shows the geographic impact of M. Gattinara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Gattinara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Gattinara more than expected).

Fields of papers citing papers by M. Gattinara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Gattinara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Gattinara. The network helps show where M. Gattinara may publish in the future.

Co-authorship network of co-authors of M. Gattinara

This figure shows the co-authorship network connecting the top 25 collaborators of M. Gattinara. A scholar is included among the top collaborators of M. Gattinara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Gattinara. M. Gattinara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effectiveness and safety of rituximab in juvenile idiopathic arthritis: Hints from the ITHACA monocentric registry 2025 ·Seminars in Arthritis and Rheumatism ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), M. Gattinara, (unknown), Maria Gerosa, Achille Marino, Roberto Caporali, Cecilia Beatrice Chighizola	0
2	Chronic Nonbacterial Osteomyelitis and Inflammatory Bowel Disease: A Literature Review-Based Cohort 2023 ·Children ·(unknown), (unknown), (unknown), (unknown), (unknown), M. Gattinara, Cecilia Beatrice Chighizola, Roberto Caporali, Achille Marino	9
3	Anti-SARS-CoV-2 vaccination in adolescent and adult patients with juvenile-onset systemic lupus erythematosus: tolerability and impact on disease activity 2023 ·Lara D. Veeken ·Cecilia Beatrice Chighizola, (unknown), (unknown), Lorenza Maria Argolini, M. Gattinara, Achille Marino, Irene Pontikaki, (unknown), Maria Gerosa	2
4	Case report: Prader–Willi syndrome and inflammatory arthritis—An important consideration 2023 ·Frontiers in Pediatrics ·(unknown), Inmaculada Tomás, Elisabetta Miserocchi, Paolo Nucci, (unknown), Orazio De Lucia, M. Gattinara, Roberto Caporali, Achille Marino	0
5	Insights into the clinical presentation of juvenile systemic lupus erythematosus: the PRAGMA monocentric cohort of 177 patients 2022 ·Clinical and Experimental Rheumatology ·Cecilia Beatrice Chighizola, (unknown), M. Gattinara, Fabrizia Corona, Achille Marino, Marta Torcoletti, Lorenza Maria Argolini, Giovanni Filocamo, (unknown), Irene Pontikaki, Stefano Lanni, Francesca Minoia, (unknown), Maria Gerosa, Carlo Agostoni, (unknown)	1
6	Henoch-Schönlein purpura following COVID-19 vaccine in a child: a case report 2022 ·The Italian Journal of Pediatrics/Italian journal of pediatrics ·(unknown), Vittoria Carlotta Magenes, (unknown), M. Gattinara, Marco Pandolfi, Stefano Cambiaghi, Gianvincenzo Zuccotti, Valentina Fabiano	7
7	Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation 2022 ·Advances in Therapy ·Orazio De Lucia, (unknown), Francesca Pregnolato, Antonella Murgo, Irene Pontikaki, M. Gattinara, (unknown), Rolando Cimaz, Roberto Caporali	4
8	Biologics for the Treatment of Juvenile Idiopathic Arthritis 2018 ·Current Medicinal Chemistry ·Dimitri Poddighe, Micol Romano, M. Gattinara, V. Gerloni	31
9	Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA) 2018 ·Annals of the Rheumatic Diseases ·Orazio De Lucia, Viviana Ravagnani, Francesca Pregnolato, (unknown), Irene Pontikaki, M. Gattinara, Micol Romano, V. Gerloni, Sara Pieropan, Antonella Murgo, Maurizio Rossini, Rolando Cimaz, Pier Luigi Meroni	42
10	Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences 2017 ·Clinical Rheumatology ·Ennio Giulio Favalli, Irene Pontikaki, Andrea Becciolini, Martina Biggioggero, Nicola Ughi, Micol Romano, Chiara Crotti, M. Gattinara, V. Gerloni, Antonio Marchesoni, Pier Luigi Meroni	35
11	Pachydermodactyly 2017 ·JCR Journal of Clinical Rheumatology ·Dimitri Poddighe, Micol Romano, M. Gattinara, V. Gerloni	3
12	Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients 2014 ·Reumatismo ·Micol Romano, Irene Pontikaki, M. Gattinara, Ilaria Ardoino, C. Donati, Patrizia Boracchi, Pier Luigi Meroni, V. Gerloni	16
13	Temporomandibular joint involvement in juvenile idiopathic arthritis: treatment with an orthodontic appliance 2011 ·Reumatismo ·(unknown), (unknown), V. Gerloni, M. Gattinara, Giampietro Farronato, F Fantini	12
14	Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy 2011 ·Reumatismo ·Gabriele De Marco, V. Gerloni, Irene Pontikaki, (unknown), (unknown), (unknown), (unknown), M. Gattinara, F Fantini	3
15	Primary Sjögren syndrome: report of a 10 years old girl with local edema and positivity of anti SS-A and anti SS-B autoantibodies 2011 ·Reumatismo ·(unknown), C. Donati, M. Gattinara, Irene Pontikaki, V. Gerloni	4
16	Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases 2011 ·Autoimmunity Reviews ·Elisabetta Miserocchi, Irene Pontikaki, Giulio Modorati, M. Gattinara, Pier Luigi Meroni, V. Gerloni	61
17	Accuracy of Wallace Criteria for Clinical Remission in Juvenile Idiopathic Arthritis: a Cohort Study of 761 Consecutive Cases 2009 ·The Journal of Rheumatology ·(unknown), (unknown), V. Gerloni, M. Gattinara, F Fantini	18
18	A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti–tumor necrosis factor α agents 2006 ·Arthritis & Rheumatism ·(unknown), Irene Pontikaki, (unknown), F. Desiati, V. Gerloni, M. Gattinara, Rolando Cimaz, F Fantini	19
19	Efficacy of repeated intravenous infusions of an anti–tumor necrosis factor α monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: Results of an open‐label prospective study 2005 ·Arthritis & Rheumatism ·V. Gerloni, Irene Pontikaki, M. Gattinara, F. Desiati, (unknown), (unknown), (unknown), F Fantini	54
20	Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup. 2003 ·PubMed ·F Fantini, V. Gerloni, M. Gattinara, Rolando Cimaz, (unknown), (unknown)	111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact